Philips introduced its new HD11 XE ultrasound system, the HD3 portable ultrasound system, and Vision 2005 upgrades to its iU22 ultrasound system at the RSNA meeting Sunday.
Philips introduced its new HD11 XE ultrasound system, the HD3 portable ultrasound system, and Vision 2005 upgrades to its iU22 ultrasound system at the RSNA meeting Sunday.
The HD11 XE is the newest version of the HD11, while the HD3 represents that company's smallest, most user-friendly HD ultrasound system. The iU22 upgrades include improved cardiology capabilities and high-quality 3D fetal imaging as well as on-cart and offline upgrades to its QLAB Quantification Software.
These upgrades are intended to provide physicians with improved high-definition imaging and accuracy and greater exam efficiency. The enhanced system features a shared-view flat panel display that accommodates both user and patient. New quantification tools provide more rapid and accurate analysis capabilities.
Exclusive SonoCT and XRES technology heighten the clarity of 3D, 4D, and multiplanar reformat imaging. The iU22 also offers advanced transducer technology, including xMATRIX array and PureWave crystal technology that enable faster image acquisition and processing.
The HD11 XE meets the demand for a multi-specialty ultrasound system. Equipped with a flat panel monitor, the system provides improved ergonomics and greater cardiac capabilities. Its M-Mode and advanced quantification features help clinicians measure heart chambers, wall motion, and ejection fraction with greater accuracy. The system is compatible with more than 20 different transducers, offering hospitals and imaging centers more options. Image and data management capabilities allow flexible recording, archiving, editing, and exam reports with embedded images.
The highly mobile HD3 system addresses clinical needs for a variety of practices. A broadband digital beam-former generates high-definition images that capture more tissue information than conventional narrowband technologies. Advanced features include tissue harmonic imaging, pulsed Doppler capability, color Doppler and color power angiography.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the